Editorial
Published on 11 Apr 2023
Editorial: Natural products as potential therapies for non-alcoholic fatty liver disease
in Ethnopharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1180263
- 1,747 views
- 2 citations
Type at least 3 characters
19,054 articles
Clinical Trial
Published on 11 Apr 2023
Evaluating the safety and efficacy of the leukotriene receptor antagonist montelukast as adjuvant therapy in obese patients with type 2 diabetes mellitus: A double-blind, randomized, placebo-controlled trial
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1153653
- 10,021 views
- 7 citations
Original Research
Published on 11 Apr 2023
Exploration of acute and chronic anti-inflammatory potential of Quercus leucotrichophora A. Camus extracts in Wistar rats: A mechanistic insight
in Ethnopharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1002999
- 3,589 views
- 12 citations
Original Research
Published on 11 Apr 2023
Cuproptosis-related molecular subtypes direct T cell exhaustion phenotypes and therapeutic strategies for patients with lung adenocarcinoma
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1146468
- 6,842 views
- 8 citations
Original Research
Published on 11 Apr 2023
The effect of CFTR modulators on structural lung disease in cystic fibrosis
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1147348
- 4,059 views
- 9 citations
Original Research
Published on 11 Apr 2023
Use of physiological based pharmacokinetic modeling for cross-species prediction of pharmacokinetic and tissue distribution profiles of a novel niclosamide prodrug
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1099425
- 5,547 views
- 8 citations
Original Research
Published on 11 Apr 2023
Single-cell transcriptomics reveals immune infiltrate in sepsis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1133145
- 8,182 views
- 14 citations
Original Research
Published on 11 Apr 2023
Cannabinoid receptor agonist attenuates angiotensin II–induced enlargement and mitochondrial dysfunction in rat atrial cardiomyocytes
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1142583
- 2,569 views
- 4 citations
Editorial
Published on 11 Apr 2023
Editorial: Novel antimicrobials and antibiotics resistance modulating agents from natural products: Turning promises into Triumphs
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1184071
- 1,789 views
- 5 citations
Original Research
Published on 11 Apr 2023
GPR35 antagonist CID-2745687 attenuates anchorage-independent cell growth by inhibiting YAP/TAZ activity in colorectal cancer cells
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1126119
- 5,213 views
- 5 citations
Editorial
Published on 11 Apr 2023
Editorial: Advances in drug-induced diseases
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1193099
- 5,274 views
- 1 citation
Original Research
Published on 10 Apr 2023
Ginsenoside Rg1 can reverse fatigue behavior in CFS rats by regulating EGFR and affecting Taurine and Mannose 6-phosphate metabolism
in Ethnopharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1163638
- 7,177 views
- 17 citations
Original Research
Published on 10 Apr 2023
The human P2X7 receptor alters microglial morphology and cytokine secretion following immunomodulation
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1148190
- 4,238 views
- 8 citations
Original Research
Published on 10 Apr 2023
Multi-omics reveals Dengzhan Shengmai formulation ameliorates cognitive impairments in D-galactose-induced aging mouse model by regulating CXCL12/CXCR4 and gut microbiota
in Ethnopharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1175970
- 3,767 views
- 8 citations
Original Research
Published on 10 Apr 2023
Predicting individual-specific cardiotoxicity responses induced by tyrosine kinase inhibitors
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1158222
- 3,943 views
- 10 citations
Original Research
Published on 10 Apr 2023
A novel signature of cuproptosis-related lncRNAs predicts prognosis in glioma: Evidence from bioinformatic analysis and experiments
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1158723
- 3,409 views
- 9 citations